Novartis Pharmaceuticals Canada Helps Canadians with Sight Loss Face Challenges of COVID-19 Head On
Wednesday, April 21 2021 | 09 h 30 min | News
CNIB thanks Novartis Pharmaceuticals Canada Inc. for their longstanding support of people with sight loss across the country.
Most recently, Novartis enabled a telephone outreach campaign to occur right when COVID-19 hit to make sure none of the CNIB participants was left behind. This involved calling more than 11,000 participants to check on their wellness and find out what support they needed.
Their generous support is also being invested in a program called Advocacy 2.0, which will help Canadians who are blind or partially sighted learn how to successfully self-advocate and stand up for their own rights.
Click HERE for the full press release.
